Who we are
The Leeds Cancer Research UK (CRUK) Radiotherapy Centre of Excellence (RadNet Leeds) is one of seven UK wide Radiotherapy Research Centres of Excellence.
Our Vision
- Improve patient outcomes in the next 5 -10 years – using personalised, adapted and novel radiotherapy in the primary and re-irradiation setting for brain, pelvic and liver cancers.
- Deliver internationally leading clinical and translational research – as a CRUK Radiotherapy Research Centre and as part of the CRUK RadNet network.
- Support and train the next generation of researchers – using our outstanding multidisciplinary training environment.
CRUK RadNet Leeds – Making the news
- RadNet Leeds researchers take a lead role in a clinical trial of a ground-breaking new radiotherapy treatment. The APPROACH trial (Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health) is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent. For more information, see here.
- £1.1 million in funding for Leeds prostate cancer trial https://yorkshirecancerresearch.org.uk/news/1-1-million-in-funding-for-leeds-prostate-cancer-trial
- Mail on Sunday https://www.dailymail.co.uk/health/article-8442699/Now-breast-lungbowel-prostate-cancer-treated-WEEK.html
Click here to view all of our RadNet Leeds Publications